DEA Approves MMJ International Holdings THC Shipment for Multiple...

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new products for an...(PRWeb November 21, 2019)Read the full story at https://www.prweb.com/releases/dea_approves_mmj_international_holdings_thc_shipment_for_multiple_sclerosis_huntington_s_disease_drug_development/prweb16742984.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals